Total Adrenalectomy Versus Subtotal Adrenalectomy for Bilateral Pheochromocytoma: Meta-analysis

Overview

Journal BJS Open

Publisher Oxford University Press

Specialty General Surgery

Date 2023 Nov 9

PMID 37945270

Authors

Donatella Schiavone

Mattia Ballo

Marco Filardo

Silvia Dughiero

Francesca Torresan

Gian Paolo Rossi

Maurizio Iacobone

Affiliations

Soon will be listed here.

Abstract

Background: Bilateral pheochromocytomas are rare and often heritable. Total adrenalectomy leads to a definitive oncological cure, with subsequent definitive hypocortisolism. Subtotal adrenalectomy is a possible alternative. The aim of this study was to assess the effects of total adrenalectomy and subtotal adrenalectomy on bilateral pheochromocytoma in terms of post-surgical rate of recurrence, metastatic disease, and steroid dependence.

Methods: Systematic searches in the bibliographic databases PubMed, Embase, and Europe PMC were performed for 1945 to 1 June 2023. PRISMA guidelines were followed and the PICO strategy was applied to English-language studies comparing subtotal adrenalectomy with total adrenalectomy. A random-effects model was used to assess the different outcomes for studies with high heterogeneity. The Newcastle-Ottawa scale and the Risk Of Bias In Non-randomized Studies of Interventions ('ROBINS-I') tool were used to assess quality and risk of bias.

Results: From a total of 12 909 studies, 1202 patients (from 10 retrospective studies) were eligible for the meta-analysis. In six studies, including 1176 patients, the recurrence rate after subtotal adrenalectomy and total adrenalectomy was 14.1 versus 2.6 per cent respectively (OR 4.91, 95 per cent c.i. 1.30 to 18.54; P = 0.020; I2 72 per cent). In nine studies, including 1124 patients, the rate of post-surgical steroid dependence was 93.3 versus 11.6 per cent after total adrenalectomy and subtotal adrenalectomy respectively (OR 0.003, 95 per cent c.i. 0.0003 to 0.03; P < 0.00001; I2 66 per cent). Based on two studies, including 719 patients, no differences were evident regarding the occurrence of post-surgery metastatic disease.

Conclusion: Subtotal adrenalectomy leads to less post-surgical primary adrenal insufficiency, but leads to a higher postoperative recurrence rate. Future prospective randomized studies, with clear eligibility criteria, are needed to confirm these results.

Citing Articles

Progress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma.

Friedman L, Ramamoorthy B, Nilubol N Best Pract Res Clin Endocrinol Metab. 2024; 39(1):101954.

PMID: 39366823 PMC: 11788041. DOI: 10.1016/j.beem.2024.101954.

Recurrent fever leading to the diagnosis of an angiosarcoma of the adrenal gland: a case report.

Lederer A, Zimmer S, Margies R, Krettek P, Musholt T J Med Case Rep. 2024; 18(1):258.

PMID: 38783354 PMC: 11118567. DOI: 10.1186/s13256-024-04583-3.

References

Tuncel A, Balci M, Aykanat C, Aslan Y, Berker D, Guzel O . Laparoscopic partial adrenalectomy using near-infrared imaging: the initial experience. Minim Invasive Ther Allied Technol. 2019; 30(2):94-100. DOI: 10.1080/13645706.2019.1691016. View

Jhawar S, Arakawa Y, Kumar S, Varghese D, Kim Y, Roper N . New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications. Cancers (Basel). 2022; 14(3). PMC: 8833412. DOI: 10.3390/cancers14030594. View

Van Heerden J, Sizemore G, Carney J, Grant C, REMINE W, Sheps S . Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg. 1984; 8(4):612-21. DOI: 10.1007/BF01654950. View

Yip L, Duh Q, Wachtel H, Jimenez C, Sturgeon C, Lee C . American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022; 157(10):870-877. PMC: 9386598. DOI: 10.1001/jamasurg.2022.3544. View

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View

Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. DOI: 10.1001/jama.283.15.2008. View

Wachtel H, Fishbein L . Genetics of pheochromocytoma and paraganglioma. Curr Opin Endocrinol Diabetes Obes. 2021; 28(3):283-290. DOI: 10.1097/MED.0000000000000634. View

Asari R, Scheuba C, Kaczirek K, Niederle B . Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Arch Surg. 2006; 141(12):1199-205. DOI: 10.1001/archsurg.141.12.1199. View

Diner E, Franks M, Behari A, Linehan W, Walther M . Partial adrenalectomy: the National Cancer Institute experience. Urology. 2005; 66(1):19-23. DOI: 10.1016/j.urology.2005.01.009. View

10.

Bima C, Bioletto F, Lopez C, Bollati M, Arata S, Procopio M . Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma. Biomedicines. 2022; 10(8). PMC: 9404897. DOI: 10.3390/biomedicines10081813. View

11.

Simforoosh N, Soltani M, Shemshaki H, Bonakdar Hashemi M, Dadpour M, Kashi A . Symptom Resolution and Recurrence Outcomes after Partial Versus Total Laparoscopic Adrenalectomy: 13 years of Experience with Medium-Long Term Follow up. Urol J. 2020; 18(2):165-170. DOI: 10.22037/uj.v16i7.6338. View

12.

Roukounakis N, Dimas S, Kafetzis I, Bethanis S, Gatsulis N, Kostas H . Is preservation of the adrenal vein mandatory in laparoscopic adrenal-sparing surgery?. JSLS. 2007; 11(2):215-8. PMC: 3015730. View

13.

Jansson S, Khorram-Manesh A, Nilsson O, Kolby L, Tisell L, Wangberg B . Treatment of bilateral pheochromocytoma and adrenal medullary hyperplasia. Ann N Y Acad Sci. 2006; 1073:429-35. DOI: 10.1196/annals.1353.046. View

14.

Nagaraja V, Eslick G, Edirimanne S . Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis. Int J Surg. 2015; 16(Pt A):7-13. DOI: 10.1016/j.ijsu.2015.01.015. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

16.

Gupta G, Benson J, Ross M, Sundaram V, Lin K, Pinto P . Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas. J Endourol. 2013; 28(1):112-6. PMC: 3880898. DOI: 10.1089/end.2013.0298. View

17.

Lerchenberger M, Gundogar U, Al Arabi N, Gallwas J, Stepp H, Hallfeldt K . Indocyanine green fluorescence imaging during partial adrenalectomy. Surg Endosc. 2019; 34(5):2050-2055. DOI: 10.1007/s00464-019-06985-7. View

18.

Scholten A, Valk G, Ulfman D, Borel Rinkes I, Vriens M . Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg. 2011; 254(6):1022-7. DOI: 10.1097/SLA.0b013e318237480c. View

19.

Nockel P, El Lakis M, Gaitanidis A, Yang L, Merkel R, Patel D . Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 2017; 163(1):191-196. PMC: 5736453. DOI: 10.1016/j.surg.2017.05.025. View

20.

ODwyer P, Chew C, Zino S, Serpell M . Long-term follow-up of patients undergoing laparoscopic surgery for phaeochromocytoma. BJS Open. 2022; 6(3). PMC: 9234194. DOI: 10.1093/bjsopen/zrac076. View